Eli Lilly & Co
LLY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000059478
In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 2 sales; 4,664 institutions reported holding it in 13F filings for Q2 2026, worth $942.9B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.
Holders of 5% or more of LLY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eli Lilly & Co, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lilly Endowment Inc | 13G/A | 9.60%90.1M shares | 0.00 ppfrom 9.60% | Jan 21, 202112 filings | Oct 19, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 6.48%61.3M shares | New | May 1, 20261 filing | May 1, 2026 | SEC |
| The PNC Financial Services Group, Inc. | 13G/A | 5.39%51.2M shares | – | Feb 12, 20216 filings | Feb 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
29 Schedule 13D and 13G filings on Eli Lilly & Co, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 19, 20263:09 PM ET | Lilly Endowment Inc | 13G/A | 9.60%90.1M shares | 0.00 ppfrom 9.60% | Sep 30, 2026 | SEC |
| Jul 23, 202610:12 AM ET | Lilly Endowment Inc | 13G/A | 9.60%90.4M shares | −0.10 ppfrom 9.70% | Jun 30, 2026 | SEC |
| May 1, 20268:38 AM ET | Vanguard Capital Management LLC | 13G | 6.48%61.3M shares | New | Mar 31, 2026 | SEC |
| Apr 20, 20263:25 PM ET | Lilly Endowment Inc | 13G/A | 9.70%91.9M shares | −0.10 ppfrom 9.80% | Mar 31, 2026 | SEC |
| Mar 26, 20266:02 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −8.55 ppfrom 8.55%Below 5% | Mar 13, 2026 | SEC |
| Jan 23, 20269:27 AM ET | Lilly Endowment Inc | 13G/A | 9.80%92.2M shares | −0.30 ppfrom 10.10% | Dec 31, 2025 | SEC |
| Oct 30, 20255:34 PM ET | Lilly Endowment Inc | 13G/A | 10.10%95.5M shares | 0.00 ppfrom 10.10% | Sep 30, 2025 | SEC |
| Oct 30, 20252:54 PM ET | Vanguard Group Inc | 13G/A | 8.55%81.0M shares | – | Sep 30, 2025 | SEC |
| Apr 16, 202511:20 AM ET | Lilly Endowment Inc | 13G/A | 10.10%96.0M shares | −0.10 ppfrom 10.20% | Mar 31, 2025 | SEC |
| Feb 7, 20258:52 AM ET | The PNC Financial Services Group, Inc. | 13G/A | 5.39%51.2M shares | – | Dec 31, 2024 | SEC |
| Jan 27, 20253:54 PM ET | Lilly Endowment Inc | 13G/A | 10.20%96.9M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | The PNC Financial Services Group, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 23, 2024 | Lilly Endowment Inc | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | The PNC Financial Services Group, Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20243:26 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2024 | Lilly Endowment Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | The PNC Financial Services Group, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20235:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 2023 | Lilly Endowment Inc | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | The PNC Financial Services Group, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 20225:12 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 27, 2022 | Lilly Endowment Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | The PNC Financial Services Group, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20219:57 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 21, 2021 | Lilly Endowment Inc | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
71 notices from officers, directors and other affiliates planning to sell Eli Lilly & Co shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 20262:55 PM ET | Lilly Endowment, Inc.Shareholder | 295.0K | $405.2M | Oct 30, 2026 | J.P. Morgan Securities LLC | SEC |
| Oct 15, 20262:44 PM ET | Lilly Endowment, Inc.Shareholder | 305.0K | $368.7M | Oct 15, 2026 | Fidelity Capital Markets | SEC |
| Oct 7, 20263:24 PM ET | Lilly Endowment, Inc.Shareholder | 300.0K | $347.2M | Oct 7, 2026 | J.P. Morgan Securities LLC | SEC |
| Aug 17, 20265:06 PM ET | Patrik JonssonOfficer | 6.50K | $7.64M | Aug 17, 202610b5-1 | Merrill Lynch | SEC |
| Aug 10, 20264:31 PM ET | Donald ZakrowskiOfficer | 2.00K | $2.37M | Aug 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 7, 202610:30 AM ET | Hakim AnatOfficer | 10.0K | $11.9M | Aug 7, 202610b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Jul 7, 20263:02 PM ET | Lilly Endowment, Inc.Shareholder | 310.0K | $372.0M | Jul 7, 2026 | Fidelity Capital Markets | SEC |
| Jun 26, 20261:40 PM ET | Lilly Endowment, Inc.Shareholder | 305.0K | $343.9M | Jun 26, 2026 | J.P. Morgan Securities LLC | SEC |
| Jun 10, 202611:03 AM ET | Yuffa IlyaOfficer | 2.50K | $2.88M | Jun 10, 202610b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| May 28, 20263:02 PM ET | Lilly Endowment, Inc.Shareholder | 310.0K | $335.7M | May 28, 2026 | Fidelity Capital Markets | SEC |
| May 22, 20262:05 PM ET | Lilly Endowment, Inc.Shareholder | 300.0K | $312.5M | May 22, 2026 | J.P. Morgan Securities LLC | SEC |
| May 20, 20264:22 PM ET | Lilly Endowment, Inc.Shareholder | 305.0K | $311.5M | May 20, 2026 | Fidelity Capital Markets | SEC |
| May 6, 20264:35 PM ET | Lilly Endowment, Inc.Shareholder | 300.0K | $296.7M | May 6, 2026 | J.P. Morgan Securities LLC | SEC |
| Dec 23, 202512:52 PM ET | Lilly Endowment, Inc.10% stockholder | 300.0K | $322.9M | Dec 23, 2025 | Fidelity Capital Markets | SEC |
| Nov 24, 20253:01 PM ET | Lilly Endowment, Inc.10% stockholder | 305.0K | $323.2M | Nov 24, 2025 | Fidelity Capital Markets | SEC |
| Nov 19, 20253:05 PM ET | Lilly Endowment, Inc.10% stockholder | 310.0K | $319.3M | Nov 19, 2025 | J.P. Morgan Securities LLC | SEC |
| Nov 13, 20253:02 PM ET | Lilly Endowment, Inc.10% stockholder | 295.0K | $300.2M | Nov 13, 2025 | Fidelity Capital Markets | SEC |
| Nov 12, 20253:15 PM ET | Lilly Endowment, Inc.10% stockholder | 305.0K | $301.5M | Nov 12, 2025 | J.P. Morgan Securities LLC | SEC |
| Nov 10, 20253:11 PM ET | Lilly Endowment, Inc.10% stockholder | 300.0K | $277.3M | Nov 10, 2025 | Fidelity Capital Markets | SEC |
| Nov 4, 20253:05 PM ET | Lilly Endowment, Inc.10% stockholder | 220.0K | $197.2M | Nov 4, 2025 | J.P. Morgan Securities LLC | SEC |
| Nov 3, 20253:06 PM ET | Lilly Endowment, Inc.10% stockholder | 300.0K | $258.9M | Nov 3, 2025 | Fidelity Capital Markets | SEC |
| Oct 10, 20252:57 PM ET | Lilly Endowment Inc10% stockholder | 305.0K | $260.9M | Oct 10, 2025 | J.P. Morgan Securities LLC | SEC |
| Oct 6, 20253:35 PM ET | Lilly Endowment Inc10% stockholder | 300.0K | $252.0M | Oct 6, 2025 | Fidelity Capital Markets | SEC |
| Oct 2, 20253:20 PM ET | Lilly Endowment Inc10% stockholder | 305.0K | $251.8M | Oct 2, 2025 | J.P. Morgan Securities LLC | SEC |
| Oct 1, 20254:08 PM ET | Lilly Endowment Inc10% stockholder | 295.0K | $225.1M | Oct 1, 2025 | Fidelity Capital Markets | SEC |
Showing the latest 25. See the LLY notices from the last 12 months